Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1985 1
1986 1
1987 2
1988 1
1989 2
1991 2
1994 4
1995 1
1996 1
2000 1
2001 2
2002 6
2003 5
2004 6
2005 3
2006 5
2007 8
2008 10
2009 11
2010 5
2011 3
2012 4
2013 1
2014 1
2015 3
2016 1
2017 3
2018 3
2019 8
2020 9
2021 12
2022 10
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.
Cho KY, Nakamura A, Omori K, Takase T, Miya A, Yamamoto K, Nomoto H, Kameda H, Taneda S, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Cho KY, et al. Among authors: taneda s. J Diabetes Investig. 2021 Jul;12(7):1272-1277. doi: 10.1111/jdi.13457. Epub 2020 Dec 2. J Diabetes Investig. 2021. PMID: 33131199 Free PMC article. Clinical Trial.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H. Kamoshima H, et al. Among authors: taneda s. Endocr J. 2022 May 30;69(5):495-509. doi: 10.1507/endocrj.EJ21-0573. Epub 2021 Nov 25. Endocr J. 2022. PMID: 34819409 Free article.
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study.
Kito K, Nomoto H, Sakuma I, Nakamura A, Cho KY, Kameda H, Miya A, Omori K, Yanagiya S, Handa T, Taneda S, Takeuchi J, Nagai S, Yamashita K, Kurihara Y, Atsumi T, Miyoshi H; PARM-T2D study group. Kito K, et al. Among authors: taneda s. Diabetes Res Clin Pract. 2022 Oct;192:110091. doi: 10.1016/j.diabres.2022.110091. Epub 2022 Sep 26. Diabetes Res Clin Pract. 2022. PMID: 36174777
121 results